US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist

16.7300
+0.6500+4.04%

Close Nov 21 16:00 ET

17.0500
+0.3200+1.91%

Post 20:01 ET

203.76MMarket Cap-3552P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

63.42%15.51M

34.18%10.99M

-44.37%9.62M

29.40%45.08M

-6.42%10.1M

15.97%9.49M

11.57%8.19M

103.08%17.3M

-38.75%34.84M

7.99%10.8M

Selling and administrative expenses

59.93%4.7M

4.64%4.12M

-1.21%3.86M

-25.61%13.91M

-31.41%3.12M

-27.90%2.94M

-18.60%3.94M

-25.28%3.91M

-8.45%18.7M

7.54%4.55M

-General and administrative expense

59.93%4.7M

4.64%4.12M

-1.21%3.86M

-25.61%13.91M

-31.41%3.12M

-27.90%2.94M

-18.60%3.94M

-25.28%3.91M

-8.45%18.7M

7.54%4.55M

Research and development costs

64.98%10.81M

61.57%6.87M

-56.97%5.76M

93.15%31.17M

11.80%6.98M

59.46%6.55M

69.98%4.25M

307.41%13.39M

-55.72%16.14M

8.31%6.24M

Operating profit

-63.42%-15.51M

-34.18%-10.99M

44.37%-9.62M

-29.40%-45.08M

6.42%-10.1M

-15.97%-9.49M

-11.57%-8.19M

-103.08%-17.3M

37.78%-34.84M

-7.99%-10.8M

Net non-operating interest income expense

205.90%808K

132.73%254K

73.89%-177.02K

-37.14%-2.92M

-10.30%-706.97K

-40.80%-763K

-58.26%-776K

-47.75%-678.02K

-16.48%-2.13M

-63.97%-640.95K

Non-operating interest income

447.93%1.19M

290.52%906K

----

--217K

--232K

----

Non-operating interest expense

-61.12%381K

-35.32%652K

----

80.85%980K

--1.01M

----

Total other finance cost

----

-73.89%177.02K

37.14%2.92M

----

47.75%678.02K

16.48%2.13M

----

Other net income (expense)

361.62%914K

307.18%737K

1,160.01%2.9M

163.17%3.4M

399.17%2.79M

439.19%198K

103.34%181K

149.92%230.24K

-144.17%-5.38M

334.71%558.72K

Gain on sale of security

1,105.00%201K

2,200.00%42K

-1,213.74%-8.11K

102.58%8.52K

-89.58%29.52K

85.30%-20K

99.05%-2K

100.27%728

-218.45%-330.59K

1,401.20%283.17K

Special income (charges)

----

--0

----

---5M

--0

-Less:Other special charges

----

--5M

--0

Other non- operating income (expenses)

227.06%713K

279.78%695K

1,167.54%2.91M

7,049.42%3.39M

901.43%2.76M

180.52%218K

187.69%183K

218.70%229.51K

-100.41%-48.77K

151.27%275.55K

Income before tax

-37.10%-13.78M

-13.81%-10M

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

Income tax

Net income

-37.10%-13.78M

-13.81%-10M

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

Net income continuous Operations

-37.10%-13.78M

-13.81%-10M

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

Minority interest income

Net income attributable to the parent company

-37.10%-13.78M

-13.81%-10M

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-37.10%-13.78M

-13.81%-10M

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

Basic earnings per share

49.34%-1.15

56.10%-0.9

80.42%-0.83

-1.58%-10.31

31.42%-1.79

-7.58%-2.27

35.53%-2.05

-87.61%-4.24

8.97%-10.15

-8.75%-2.61

Diluted earnings per share

49.34%-1.15

56.10%-0.9

80.42%-0.83

-1.58%-10.31

31.42%-1.79

-7.58%-2.27

35.53%-2.05

-87.61%-4.24

8.97%-10.15

-8.75%-2.61

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	63.42%15.51M	34.18%10.99M	-44.37%9.62M	29.40%45.08M	-6.42%10.1M	15.97%9.49M	11.57%8.19M	103.08%17.3M	-38.75%34.84M	7.99%10.8M
Selling and administrative expenses	59.93%4.7M	4.64%4.12M	-1.21%3.86M	-25.61%13.91M	-31.41%3.12M	-27.90%2.94M	-18.60%3.94M	-25.28%3.91M	-8.45%18.7M	7.54%4.55M
-General and administrative expense	59.93%4.7M	4.64%4.12M	-1.21%3.86M	-25.61%13.91M	-31.41%3.12M	-27.90%2.94M	-18.60%3.94M	-25.28%3.91M	-8.45%18.7M	7.54%4.55M
Research and development costs	64.98%10.81M	61.57%6.87M	-56.97%5.76M	93.15%31.17M	11.80%6.98M	59.46%6.55M	69.98%4.25M	307.41%13.39M	-55.72%16.14M	8.31%6.24M
Operating profit	-63.42%-15.51M	-34.18%-10.99M	44.37%-9.62M	-29.40%-45.08M	6.42%-10.1M	-15.97%-9.49M	-11.57%-8.19M	-103.08%-17.3M	37.78%-34.84M	-7.99%-10.8M
Net non-operating interest income expense	205.90%808K	132.73%254K	73.89%-177.02K	-37.14%-2.92M	-10.30%-706.97K	-40.80%-763K	-58.26%-776K	-47.75%-678.02K	-16.48%-2.13M	-63.97%-640.95K
Non-operating interest income	447.93%1.19M	290.52%906K	----	----	----	--217K	--232K	----	----	----
Non-operating interest expense	-61.12%381K	-35.32%652K	----	----	----	80.85%980K	--1.01M	----	----	----
Total other finance cost	----	----	-73.89%177.02K	37.14%2.92M	----	----	----	47.75%678.02K	16.48%2.13M	----
Other net income (expense)	361.62%914K	307.18%737K	1,160.01%2.9M	163.17%3.4M	399.17%2.79M	439.19%198K	103.34%181K	149.92%230.24K	-144.17%-5.38M	334.71%558.72K
Gain on sale of security	1,105.00%201K	2,200.00%42K	-1,213.74%-8.11K	102.58%8.52K	-89.58%29.52K	85.30%-20K	99.05%-2K	100.27%728	-218.45%-330.59K	1,401.20%283.17K
Special income (charges)	----	----	----	--0	----	----	----	----	---5M	--0
-Less:Other special charges	----	----	----	----	----	----	----	----	--5M	--0
Other non- operating income (expenses)	227.06%713K	279.78%695K	1,167.54%2.91M	7,049.42%3.39M	901.43%2.76M	180.52%218K	187.69%183K	218.70%229.51K	-100.41%-48.77K	151.27%275.55K
Income before tax	-37.10%-13.78M	-13.81%-10M	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M
Income tax
Net income	-37.10%-13.78M	-13.81%-10M	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M
Net income continuous Operations	-37.10%-13.78M	-13.81%-10M	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M
Minority interest income
Net income attributable to the parent company	-37.10%-13.78M	-13.81%-10M	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-37.10%-13.78M	-13.81%-10M	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M
Basic earnings per share	49.34%-1.15	56.10%-0.9	80.42%-0.83	-1.58%-10.31	31.42%-1.79	-7.58%-2.27	35.53%-2.05	-87.61%-4.24	8.97%-10.15	-8.75%-2.61
Diluted earnings per share	49.34%-1.15	56.10%-0.9	80.42%-0.83	-1.58%-10.31	31.42%-1.79	-7.58%-2.27	35.53%-2.05	-87.61%-4.24	8.97%-10.15	-8.75%-2.61
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data